Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Down 37.0% in May

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the target of a significant drop in short interest during the month of May. As of May 29th, there was short interest totaling 1,278,919 shares, a drop of 37.0% from the May 14th total of 2,031,410 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Genomma Lab Internacional Stock Performance

Shares of OTCMKTS GNMLF remained flat at $0.84 during mid-day trading on Wednesday. 9,000 shares of the stock traded hands, compared to its average volume of 1,800. The business has a 50-day moving average of $1.06 and a 200-day moving average of $1.03. Genomma Lab Internacional has a 52-week low of $0.84 and a 52-week high of $1.27.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.